Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,277 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Angiotensin Receptor-Neprilysin Inhibitor Suppresses Renin-Angiotensin-Aldosterone System Activation After Cardiac Surgery Using Cardiopulmonary Bypass.
Hoshino J, Saito S, Shibasaki I, Sairenchi T, Okubo S, Matsuoka T, Hirota S, Yokoyama S, Kanazawa Y, Tezuka M, Takei Y, Tsuchiya G, Konishi T, Ogata K, Fukuda H. Hoshino J, et al. Among authors: hirota s. Circ J. 2024 Apr 24. doi: 10.1253/circj.CJ-23-0879. Online ahead of print. Circ J. 2024. PMID: 38658351 Free article.
CD8+ T cell-mediated rejection of allogenic human induced pluripotent stem cell-derived cardiomyocyte sheets in human PBMC-transferred NOG MHC double knockout mice.
Matsumoto R, Enzhi Y, Takeda K, Morimoto K, Yogo K, Harada M, Tokushige K, Maehara Y, Hirota S, Kojima Y, Ito M, Sougawa N, Miyagawa S, Sawa Y, Okumura K, Uchida K. Matsumoto R, et al. Among authors: hirota s. J Heart Lung Transplant. 2024 Apr 22:S1053-2498(24)01564-X. doi: 10.1016/j.healun.2024.04.003. Online ahead of print. J Heart Lung Transplant. 2024. PMID: 38657776
English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical Oncology.
Hirota S, Tateishi U, Nakamoto Y, Yamamoto H, Sakurai S, Kikuchi H, Kanda T, Kurokawa Y, Cho H, Nishida T, Sawaki A, Ozaka M, Komatsu Y, Naito Y, Honma Y, Takahashi F, Hashimoto H, Udo M, Araki M, Nishidate S; Members of the Systematic Review Team of the Present Guidelines. Hirota S, et al. Int J Clin Oncol. 2024 Apr 13. doi: 10.1007/s10147-024-02488-1. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38609732
Efficacy and Safety of Transitioning to Lemborexant from Z-drug, Suvorexant, and Ramelteon in Japanese Insomnia Patients: An Open-label, Multicenter Study.
Ozone M, Hirota S, Ariyoshi Y, Hayashida K, Ikegami A, Habukawa M, Ohshima H, Harada D, Hiejima H, Kotorii N, Murotani K, Taninaga T, Uchimura N. Ozone M, et al. Among authors: hirota s. Adv Ther. 2024 Apr;41(4):1728-1745. doi: 10.1007/s12325-024-02811-2. Epub 2024 Mar 9. Adv Ther. 2024. PMID: 38460107 Free PMC article. Clinical Trial.
Reply to comment on 'An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers' by Fukui et al.
Fukui R, Watanabe T, Morimoto K, Fujimoto Y, Nagahashi M, Ishikawa E, Hirota S, Miyoshi Y. Fukui R, et al. Among authors: hirota s. Breast Cancer. 2024 May;31(3):536-538. doi: 10.1007/s12282-024-01552-y. Epub 2024 Mar 4. Breast Cancer. 2024. PMID: 38433180 No abstract available.
1,277 results